Tolerated wasp sting challenge improves health-related quality of life in patients allergic to wasp venom
Authors:
- Jörg FischerJFJörg Fischer
- Martin TeufelMTMartin Teufel
- Alexandra FeidtAFAlexandra Feidt
- Katrin Elisabeth GielKGKatrin Elisabeth Giel
- Stephan ZipfelStephan Zipfel
- Tilo BiedermannTBTilo Biedermann
- 1 August 2013
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 132 (2) , 489-490
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Immunotherapy improves health‐related quality of life of adult patients with dermal reactions following yellow jacket stingsClinical & Experimental Allergy, 2009
- Quality of life in insect venom allergic patientsCurrent Opinion in Allergy and Clinical Immunology, 2003
- Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venomJournal of Allergy and Clinical Immunology, 2002
- Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom dosesJournal of Allergy and Clinical Immunology, 2001
- Determining a minimal important change in a disease-specific quality of life questionnaireJournal of Clinical Epidemiology, 1994